From: Oncogenic roles of the lncRNA LINC00460 in human cancers
Cancer type | Expression in tissue | Sample size | Expression in cancer cells | Cancer cell lines | Relative normal cell lines | Functional role | Refs. |
---|---|---|---|---|---|---|---|
Acute myeloid leukemia | Up | 80 | Up | THP1, KG1, ME1, HL60 | HS5 | Proliferation, apoptosis, cell cycle | [36] |
Bladder cancer | Up | 43 | Up | T-24, 5637,SW780, RT-112 | SV-HUC-1 | Proliferation, migration, invasion | [13] |
 | – | – | Up | 5637, T24 | SV-HUC-1 | Proliferation, migration | [14] |
Breast cancer | Up | 42 | Up | MCF-7, BT-474, MDA-MB-231, BT-549 | MCF-10Â A | Proliferation, migration, invasion | [15] |
Cervical cancer | Up | 20 | Up | HeLa, CaSki | – | Proliferation, invasion, cell cycle | [16] |
 | Up | 30 | – | SiHa, C-33 A, HeLa, CaSki | – | Proliferation, apoptosis, cell cycle | [17] |
Colon cancer | – | – | Up | HT-29, HCT-116, SW480, LOVO | NCM-460 | Proliferation, invasion, EMT | [19] |
 | Up | 36 | Up | H460, A549, SK-MES-1, and H1299) | NHBE | Invasion, chemoresistance | [18] |
Colorectal cancer | Up | 60 | Up | HCT116, SW480, HT-29, Lovo | HcoEpiC | Proliferation, apoptosis | [10] |
 | Up | 92 | Up | SW620, HCT116, CX-1, HT29 | NCM460 | proliferation, cell cycle | [24] |
 | Up | 74 | Up | HT29, HCT116, SW480, and LOVO | NCM460 | Proliferation, migration, invasion, apoptosis | [21] |
 | Up | 62 | Up | HCT-15, HCT-116, SW480, SW620, RKO, LoVo, HT-29 | CCD841CoN | Proliferation, migration, invasion, EMT | [60] |
 | Up | 74 | Up | HT29, HCT116, SW480, LOVO | NCM460 | Pigration, invasion | [22] |
 | Up | 498 | Up | SW480, SW620, HCT116, DLD1, LOVO, HT29 | FHC | Proliferation, migration, invasion | [20] |
 | Up | 40 | Up | HCT116, HT–29 | FHC | Migration, invasion | [23] |
 | Up | 21 | – | – | – | Chemoresistance | [64] |
Epithelial ovarian cancer | Up | 98 | Up | SKOV3, A2780, OVCAR, HO–8910 | HOSEpiC | – | [28] |
Esophageal cancer | – | – | Up | EC1, EC9706, KYSE70, TE1, TE13 | Het-1 A | Migration, invasion, EMT | [61] |
 | Up | 65 | Up | EC109, KYSE150, KYSE450 | Het-1 A | Proliferation, apoptosis | [25] |
Gastric cancer | Up | 60 | Up | MGC803, BGC823 and SGC7901) | GSE1 | Proliferation, migration, invasion, cell cycle | [53] |
 | Up | 80 | Up | (BGC823, AGS, SGC7901, and MGC803 | GES1 | Proliferation, apoptosis, cell cycle | [26] |
 | Up | 90 | Up | BGC-823, SGC-7901, MKN-28, MKN-45 | GES-1 | Proliferation, invasion, cell cycle | [27] |
Glioma | Up | 42 | Up | U87, U251, LN229, A172 | NHA | Proliferation, migration, invasion, apoptosis | [37] |
Head and neck squamous cell carcinoma | Up | 15 | Up | CAL-27, WSU-HN4, WSUHN6 | HOEC | Proliferation, migration,EMT, apoptosis | [38] |
 | Up | 60 | Up | HSC3, Fadu, SAS | HACA | Proliferation, migration, invasion, EMT | [39] |
 | Up | 123 | Up | WSU–HN4, WSUHN6, WSU-HN30, SCC-4, SCC-9, SCC-25 and CAL-27 | Normal oral epithelial cells | Proliferation, migration, invasion, EMT | [41] |
 | Up | 54 | – | PCI-13, FaDu, SCC-15, UM-SCC-10 A | – | Apoptosis, autophagy, cell cycle | [42] |
Hepatocellular carcinoma | Up | 60 | Up | SNU423, Hep3B, HuH7, SK-Hep-1 | HS-5 | Proliferation, migration, invasion, apoptosis | [43] |
 | Up | 60 | Up | HepG2, Hep3B, SNU-449, THLE-3, HCCLM3, | Huh-7, LO2 | Proliferation, migration, invasion, apoptosis | [44] |
 | Up | 50 | Up | HepG2, Huh7, SMMC7721, BEL-7402,HCCLM3, SK-HEP-1 | LO2 | Proliferation, migration, invasion, cell cycle | [45] |
Laryngeal squamous cell carcinoma | Up | 68 | – | – | – | – | [46] |
Lung cancer | Up | 50 | Up | H157, 95D, SPC-A-1, A549, SK-LU-1, Calu-3, HCC-78, H1299, H1975 | 16HBE | Proliferation | [11] |
 | Up | 52 | Up | A549, H226, H1915, SPCA–1, PC–9 | 16HBE | Proliferation, migration, invasion, EMT | [29] |
 | Up | 36 | Up | H460, A549, SK-MES-1, and H1299 | NHBE | Proliferation, invasion, chemoresistance | [30] |
 | Up | 8 | Up | A549, H1299, H1975, H460, PC9, SPC-A1 | Beas-2B | Migration, invasion, EMT | [31] |
Meningioma | Up | 33 | Up | (IOMM-Lee, CH157-MN) | Ben–Men-1 | Proliferation, invasion, apoptosis | [47] |
Nasopharyngeal carcinoma | Up | 50 | Up | SUNE-1, CNE-1, HNE-1, CNE-2, C666-1, HONE-1 | NP69 | Proliferation | [48] |
Osteosarcoma | Up | 31 | Up | Saos-2, HOS, U2OS, MG63 | hFOB 1.19 | Proliferation, migration, invasion | [49] |
Pancreatic cancer | Up | 59 | – | – | – | Proliferation | [32] |
Papillary thyroid cancer | Up | 58 | Up | 5CTPC1, BCPAP, FTC-133, 8505Â C | Nthyori 3-1 | Proliferation, migration, invasion, EMT | [33] |
 | Up | 48 | Up | TPC-1, BCPAP, IHH-4 | Nthyori 3-1 | Proliferation, migration, invasion | [34] |
 | – | – | Up | K1, TPC-1 | Nthyori 3-1 | Proliferation, invasion, apoptosis | [35] |